Complex Regional Pain Syndrome (CRPS) — Academic Assignment

COMPLEX REGIONAL PAIN

SYNDROME
(CRPS)
A Comprehensive Academic Assignment

Subject Pathophysiology & Clinical Management

Topic Complex Regional Pain Syndrome (CRPS)
Course Advanced Pain Medicine / Neuroscience
Submitted By ___________________________
Student ID ___________________________
Date April 2026
Institution ___________________________
Instructor ___________________________

Abstract
Complex Regional Pain Syndrome (CRPS) is a chronic, debilitating pain condition characterized
by persistent disproportionate pain, autonomic dysfunction, sensory abnormalities, and trophic
changes, typically affecting one or more extremities. This assignment provides a comprehensive
overview of CRPS, encompassing its definition, classification, epidemiology, pathophysiology,
clinical features, diagnostic criteria, and both pharmacological and non-pharmacological
management strategies. The assignment also examines prognosis, complications, and future
directions in research. CRPS remains one of the most challenging and poorly understood pain
conditions, requiring a multidisciplinary approach for optimal patient outcomes.

Page 1 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

Keywords: CRPS, Complex Regional Pain Syndrome, neuropathic pain, allodynia,

hyperalgesia, sympathetically maintained pain, Budapest criteria, multidisciplinary pain
management

1. Introduction
Complex Regional Pain Syndrome (CRPS) is a chronic and often severely disabling pain
disorder that typically develops following trauma, surgery, or other tissue injury, although it may
sometimes arise without any identifiable precipitating event. It is characterized by an unusual
constellation of symptoms that are disproportionate in intensity and duration to the initiating
injury. These symptoms include severe, burning pain; abnormal sensory processing; autonomic
and vasomotor instability; trophic changes to skin, hair, and nails; and motor dysfunction.

Historically known under a variety of names — including Reflex Sympathetic Dystrophy (RSD),
Causalgia, Sudeck's atrophy, Algodystrophy, and Shoulder-Hand Syndrome — the condition
was unified under the term 'Complex Regional Pain Syndrome' by the International Association
for the Study of Pain (IASP) in 1994, to better reflect its complex, multifactorial nature.

CRPS poses significant diagnostic and therapeutic challenges. The mechanisms underlying the
condition involve a complex interplay of peripheral and central sensitization, neuroinflammation,
autonomic dysregulation, and central nervous system reorganization. Due to its variable
presentation and lack of a definitive diagnostic test, CRPS is frequently misdiagnosed or under-
recognized, resulting in delayed treatment and poorer outcomes for patients.

2. Classification of CRPS
CRPS is broadly divided into two subtypes based on the presence or absence of a confirmed
nerve injury:

2.1 CRPS Type I (Reflex Sympathetic Dystrophy - RSD)

CRPS Type I occurs without confirmed peripheral nerve injury. It is the more common subtype,
accounting for approximately 90% of cases. It typically follows a seemingly minor injury such as
a sprain, fracture, or surgical procedure, but the pain and associated features are grossly
disproportionate to the inciting event. Historically referred to as Reflex Sympathetic Dystrophy
(RSD) or Sudeck's atrophy.

2.2 CRPS Type II (Causalgia)

CRPS Type II is distinguished by confirmed injury to a peripheral nerve. It was previously known
as Causalgia. Although the nerve injury is identifiable, the symptoms — particularly allodynia
and hyperalgesia — extend well beyond the distribution of the injured nerve. It is less common
than Type I but generally associated with more severe and persistent symptomatology.

Page 2 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

2.3 Comparison Table: CRPS Type I vs. Type II

Feature CRPS Type I (RSD) CRPS Type II (Causalgia)

Nerve Injury No confirmed nerve injury Confirmed peripheral nerve
injury
Cause Minor trauma, fracture, surgery Direct nerve damage
Pain Pattern Diffuse, disproportionate Often follows nerve distribution
Incidence More common (~90%) Less common (~10%)
Prognosis Variable Generally more severe

3. Epidemiology
The true prevalence of CRPS is difficult to ascertain owing to inconsistency in diagnostic criteria
and underdiagnosis. However, epidemiological studies provide the following general estimates:

• Incidence: Estimated at 5.46 to 26.2 per 100,000 person-years in various population

studies.
• Sex Distribution: CRPS is significantly more common in females, with a female-to-male
ratio of approximately 3–4:1.
• Age of Onset: It can occur at any age but is most commonly reported between 40 and 70
years of age. Pediatric CRPS, though less frequent, has been increasingly recognized.
• Affected Limbs: The upper extremity (especially the wrist and hand) is more commonly
affected than the lower extremity. Some patients develop CRPS in both limbs (bilateral
CRPS).
• Precipitating Factors: Fractures are the most common precipitating events (especially
distal radius fractures). Other causes include surgery, sprains, immobilization, and in
some cases, no identifiable trigger.

4. Pathophysiology
The pathophysiology of CRPS is complex and multifactorial, involving several overlapping
mechanisms that are not yet fully elucidated. Key mechanisms include:

4.1 Peripheral Sensitization

Following tissue or nerve injury, there is enhanced sensitivity of nociceptors in the affected
region. Inflammatory mediators such as substance P, bradykinin, prostaglandins, and cytokines

Page 3 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

sensitize peripheral nociceptors, lowering their activation thresholds. This manifests clinically as
allodynia (pain from normally non-painful stimuli) and hyperalgesia (exaggerated pain response
to painful stimuli).

4.2 Central Sensitization

Central sensitization refers to increased excitability of neurons within the central nervous
system. In CRPS, there is evidence of wind-up phenomenon, long-term potentiation, and
reduced descending inhibition from supraspinal centers. This contributes to the spread of pain
beyond the initial injury site and the persistence of pain well after tissue healing has occurred.

4.3 Neuroinflammation
CRPS is associated with a pronounced neuroinflammatory response. Elevated levels of pro-
inflammatory neuropeptides (such as substance P and calcitonin gene-related peptide [CGRP])
contribute to vasodilation, edema, and sensitization of nociceptors. There is also evidence of
autoimmune involvement, with autoantibodies directed against autonomic receptors (e.g., beta-
2 adrenoceptors and muscarinic M2 receptors) identified in some patients.

4.4 Sympathetic Nervous System Dysfunction

CRPS has long been associated with sympathetic nervous system abnormalities.
Sympathetically Maintained Pain (SMP) is a subtype in which pain is mediated or sustained by
sympathetic efferent activity. Aberrant coupling between sympathetic and afferent fibers may
contribute to vasomotor instability, sweating abnormalities, and maintenance of pain through
norepinephrine-mediated nociceptor activation.

4.5 Cortical Reorganization

Neuroimaging studies have demonstrated alterations in somatosensory and motor cortical
representations in CRPS patients. There is shrinkage of the cortical representation of the
affected limb, contributing to motor dysfunction and body schema disturbances. These changes
can partly reverse with effective treatment, suggesting neuroplasticity plays a dual role in the
pathophysiology and recovery of CRPS.

4.6 Psychological and Psychosocial Factors

While CRPS is a biological condition, psychological factors including anxiety, depression, pain
catastrophizing, and maladaptive coping strategies have been shown to influence its course and
severity. These factors may amplify central sensitization and impair recovery, necessitating
psychological assessment and intervention as part of comprehensive care.

Page 4 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

5. Clinical Features
CRPS presents with a diverse and dynamic range of symptoms that may change over time. The
cardinal features are grouped into four main categories:

5.1 Sensory Abnormalities

• Allodynia: Pain elicited by normally non-noxious stimuli (e.g., light touch, temperature
change).
• Hyperalgesia: Exaggerated pain response to noxious stimuli.
• Hyperpathia: Abnormally painful reaction, especially to repetitive stimuli.
• Spontaneous burning pain: A hallmark feature; constant and severe.
• Hypoesthesia or hyperesthesia may also be present.

5.2 Autonomic Disturbances

• Vasomotor changes: Skin color changes (red, purple, pale, mottled).
• Temperature asymmetry: Affected limb may be warmer (acute phase) or cooler (chronic
phase) than the contralateral limb.
• Sudomotor changes: Excessive sweating (hyperhidrosis) or reduced sweating.
• Edema: Swelling of the affected limb, often visible and pitting in early stages.

5.3 Motor Dysfunction

• Reduced range of motion and weakness.
• Tremors and involuntary movements.
• Dystonia and fixed posturing of the affected limb.
• Difficulty initiating or completing voluntary movements.

5.4 Trophic Changes

• Skin: Shiny, atrophic, or thickened skin in the affected region.
• Nails: Abnormal nail growth (brittle, ridged, or hypertrophied).
• Hair: Increased or decreased hair growth.
• Soft tissues and bones: Osteoporosis or patchy bone demineralization on imaging.

Page 5 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

6. Diagnostic Criteria
CRPS lacks a definitive biomarker or diagnostic test; diagnosis is primarily clinical. The
Budapest Clinical Diagnostic Criteria (2003, revised) represent the current gold standard and
require all of the following:

6.1 Budapest Criteria (Clinical Diagnosis)

1. Continuing pain, which is disproportionate to any inciting event.
2. Must report at least ONE symptom in THREE or more of the following four categories:
• Sensory: Reports of hyperesthesia and/or allodynia.
• Vasomotor: Reports of temperature asymmetry and/or skin color changes.
• Sudomotor/Edema: Reports of edema and/or sweating changes.
• Motor/Trophic: Reports of decreased range of motion, motor dysfunction, and/or trophic
changes.
3. Must display at least ONE sign at time of evaluation in TWO or more of the above
categories.
4. No other diagnosis better explains the signs and symptoms.

6.2 Investigations
While no single investigation confirms CRPS, the following may support diagnosis and rule out
other conditions:
• Plain X-ray: May reveal patchy osteoporosis (Sudeck's atrophy) in later stages.
• Three-phase bone scintigraphy: Increased periarticular uptake in the affected limb; more
useful in early stages.
• MRI: May show marrow edema, periarticular soft tissue changes, and exclude other
diagnoses.
• Thermography: Demonstrates temperature asymmetry between limbs.
• Quantitative Sudomotor Axon Reflex Test (QSART): Evaluates sudomotor function.
• Laboratory tests: Primarily to exclude differential diagnoses (e.g., infection, autoimmune
disease).

7. Differential Diagnosis
Due to its protean manifestations, CRPS must be differentiated from a range of conditions:
• Peripheral vascular disease (DVT, arterial insufficiency)
• Peripheral neuropathy (diabetic, metabolic)
• Raynaud's phenomenon
• Inflammatory arthritis (rheumatoid arthritis, gout)
• Infection (osteomyelitis, cellulitis)

Page 6 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

• Thoracic outlet syndrome

• Erythromelalgia
• Conversion disorder / functional neurological symptom disorder

8. Management
The management of CRPS is complex and best achieved through a multidisciplinary team
approach involving pain specialists, physiotherapists, occupational therapists, psychologists,
and other healthcare professionals. Treatment is guided by symptom severity, stage of disease,
and individual patient needs.

8.1 Pharmacological Management

8.1.1 Analgesics
• NSAIDs: Useful in mild-to-moderate pain and early inflammatory stages; limited long-
term efficacy.
• Opioids: May provide short-term relief but risk of dependence and limited evidence for
chronic CRPS; used cautiously.
• Tramadol: Has both opioid and noradrenergic/serotonergic activity; modest evidence.

8.1.2 Neuropathic Pain Agents

• Gabapentin / Pregabalin: Alpha-2-delta ligands that reduce central sensitization; widely
used.
• Tricyclic Antidepressants (amitriptyline, nortriptyline): Beneficial for neuropathic pain and
sleep disturbance.
• SNRIs (duloxetine, venlafaxine): Increasing role in neuropathic pain management.

8.1.3 Bisphosphonates
• Alendronate, Pamidronate, Clodronate: Have shown significant analgesic and anti-
inflammatory benefits in CRPS, particularly in the acute phase with bone involvement.

8.1.4 Corticosteroids
• Prednisolone / Methylprednisolone: Useful in the acute inflammatory phase; short
courses may reduce edema and pain.

8.1.5 Topical Agents

• Topical lidocaine (5%): For localized allodynia.
• Capsaicin cream/patch: Desensitizes TRPV1 receptors; may reduce burning pain.

Page 7 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

• Topical ketamine: Emerging evidence for NMDA receptor blockade at the site of pain.

8.1.6 Ketamine Infusions

• IV or subcutaneous ketamine infusions: Used for refractory CRPS; involves NMDA
antagonism to disrupt central sensitization. Administered under close monitoring.

8.2 Interventional Procedures

• Sympathetic nerve blocks: Stellate ganglion block (upper limb) or lumbar sympathetic
block (lower limb); targets sympathetically maintained pain.
• Intravenous regional sympathetic block (Bier's block): With guanethidine or bretylium.
• Epidural analgesia: For severe or bilateral CRPS.
• Spinal Cord Stimulation (SCS): Strong evidence base; involves implanting electrodes
near the spinal cord to modulate pain signals. Recommended for refractory CRPS.
• Intrathecal drug delivery: Baclofen or opioid infusions for severe, refractory cases.

8.3 Physical and Rehabilitation Therapy

Physical rehabilitation is the cornerstone of CRPS management and should be initiated as early
as possible:
• Physiotherapy: Graded motor imagery (GMI), mirror therapy, desensitization techniques,
and graded exposure to movement.
• Graded Motor Imagery (GMI): A three-stage program involving left/right discrimination,
motor imagery, and mirror therapy; shown to reduce pain and improve function.
• Mirror Therapy: Uses a mirror to create visual illusion of normal limb movement;
modulates cortical reorganization.
• Occupational Therapy: Functional reintegration, assistive devices, and activity
modification.
• Hydrotherapy: Warm water exercise may reduce pain and improve range of motion.

8.4 Psychological Management

• Cognitive Behavioral Therapy (CBT): Addresses pain catastrophizing, fear-avoidance
behavior, and depression.
• Acceptance and Commitment Therapy (ACT): Promotes psychological flexibility and
functional engagement.
• Mindfulness-Based Stress Reduction (MBSR): Reduces pain-related distress.
• Pain education and self-management strategies.

8.5 Emerging and Experimental Therapies

• Low-dose naltrexone: Modulates glial cell activation and neuroinflammation.

Page 8 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

• Immunotherapy (IVIG, rituximab): Based on autoimmune hypothesis; early evidence in

select patients.
• Repetitive Transcranial Magnetic Stimulation (rTMS): Non-invasive brain stimulation
targeting motor cortex; may reduce cortical reorganization.
• Virtual reality therapy: Emerging modality for pain modulation and functional
rehabilitation.

9. Stages of CRPS
Traditionally, CRPS was described as progressing through three stages, though this staging
model is now considered an oversimplification as not all patients progress through each stage
linearly:

• Stage 1 (Acute, 0–3 months): Severe burning pain, hyperalgesia, allodynia, warm and
red skin, edema, hyperhidrosis, hair/nail growth changes.
• Stage 2 (Dystrophic, 3–12 months): Pain persists; skin becomes cool, cyanotic, and
thickened; edema decreases; osteoporosis begins; joint stiffness increases.
• Stage 3 (Atrophic, >12 months): Irreversible changes including atrophic skin and muscle,
severe contractures, marked osteoporosis, and spread of symptoms to other limbs.

Modern understanding acknowledges that CRPS presentation is highly variable and individuals
may plateau at any stage or even improve, particularly with early intervention.

10. Prognosis
The prognosis of CRPS is variable and depends on multiple factors:
• Duration of symptoms before diagnosis and treatment: Earlier intervention is associated
with better outcomes.
• Age and sex: Younger patients, particularly children, tend to have better outcomes.
Women may have more severe and protracted courses.
• Presence of psychological comorbidities: Depression, anxiety, and catastrophizing
worsen prognosis.
• Severity of initial injury: More severe injuries and confirmed nerve damage (CRPS II)
tend to have worse prognoses.

Studies suggest that approximately 30–40% of patients achieve significant improvement or

remission, while the remainder develop chronic, disabling symptoms. Pediatric CRPS generally
carries a more favorable prognosis, with high rates of full recovery following rehabilitation.

Page 9 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

11. Complications
If CRPS is left untreated or inadequately managed, several serious complications may arise:
• Permanent contractures and limb deformities: Loss of function due to disuse and
dystonic posturing.
• Osteoporosis and fragility fractures: Particularly in the affected limb.
• Skin ulceration: Secondary to vasomotor changes and reduced tissue perfusion.
• Psychological sequelae: Severe depression, anxiety disorders, PTSD, and social
isolation.
• Spread of CRPS: Extension to other limbs (mirror-image or ipsilateral spread).
• Medication dependency: Risk of opioid dependence with prolonged pharmacotherapy.

12. Nursing Considerations

Nurses play a pivotal role in the holistic management of CRPS patients:
• Pain Assessment: Use validated tools (NRS, VAS, LANSS) regularly; document
temporal patterns, triggers, and associated features.
• Patient Education: Educate patients and families about the nature of CRPS, realistic
treatment expectations, and self-management strategies.
• Medication Management: Monitor for efficacy and adverse effects of complex analgesic
regimens including opioids, anticonvulsants, and antidepressants.
• Psychological Support: Screen for depression and anxiety; provide empathetic
communication; refer to psychology services as appropriate.
• Rehabilitation Coordination: Facilitate physiotherapy, occupational therapy, and pain
clinic appointments.
• Skin Care: Monitor for trophic skin changes, implement pressure care protocols, and
prevent secondary complications.
• Safety: Assess for falls risk due to motor dysfunction; implement appropriate mobility
aids.

13. Conclusion
Complex Regional Pain Syndrome is a challenging, multidimensional pain disorder that remains
incompletely understood despite decades of research. Its pathophysiology involves an intricate
interplay of peripheral and central sensitization, neuroinflammation, autonomic dysregulation,
cortical reorganization, and psychosocial factors. The absence of a definitive diagnostic
biomarker underscores the continued reliance on clinical criteria such as the Budapest criteria
for diagnosis.

Effective management demands a patient-centered, multidisciplinary approach encompassing

pharmacological, interventional, rehabilitative, and psychological strategies. Early diagnosis and
treatment initiation are paramount in preventing progression to chronic, debilitating disease.

Page 10 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

Emerging therapies — including immunotherapy, neuromodulation, and virtual reality

rehabilitation — offer hope for patients refractory to conventional treatments.

Future research directions include the development of objective biomarkers, randomized

controlled trials of emerging therapies, and a deeper understanding of the genetic,
immunological, and neurological substrates of CRPS. Raising awareness among clinicians of all
specialties about the early signs of CRPS is critical to improving patient outcomes globally.

References
Harden, R. N., Bruehl, S., Perez, R. S., Birklein, F., Marinus, J., Maihofner, C., ... & Vatine, J. J.
(2010). Validation of proposed diagnostic criteria (the 'Budapest Criteria') for Complex Regional
Pain Syndrome. Pain, 150(2), 268-274.

de Mos, M., de Bruijn, A. G. J., Huygen, F. J. P. M., Dieleman, J. P., Stricker, B. H. C., &
Sturkenboom, M. C. J. M. (2007). The incidence of complex regional pain syndrome: a
population-based study. Pain, 129(1-2), 12-20.

Bruehl, S. (2015). Complex regional pain syndrome. British Medical Journal, 351, h2730.

Moseley, G. L. (2004). Graded motor imagery is effective for long-standing complex regional
pain syndrome: a randomised controlled trial. Pain, 108(1-2), 192-198.

Stanton-Hicks, M. (2006). Complex regional pain syndrome: manifestations and the role of
neurostimulation in its management. Journal of Pain and Symptom Management, 31(4), S20-
S24.

International Association for the Study of Pain (IASP). (2021). CRPS: Chronic Primary Pain.
IASP Taxonomy. Retrieved from [Link]

Gierthmuhlen, J., Binder, A., & Baron, R. (2014). Mechanism-based treatment in complex
regional pain syndromes. Nature Reviews Neurology, 10(9), 518-528.

Royal College of Physicians. (2018). Complex regional pain syndrome in adults: UK guidelines
for diagnosis, referral and management in primary and secondary care. London: RCP.

Coderre, T. J., Xanthos, D. N., Francis, L., & Bennett, G. J. (2004). Chronic post-ischemia pain
(CPIP): a novel animal model of complex regional pain syndrome-type I produced by prolonged
hindpaw ischemia and reperfusion in the rat. Pain, 112(1-2), 94-105.

Page 11 | Complex Regional Pain Syndrome

Complex Regional Pain Syndrome (CRPS) — Academic Assignment

Marinus, J., Moseley, G. L., Birklein, F., Baron, R., Maihofner, C., Kingery, W. S., & van Hilten,
J. J. (2011). Clinical features and pathophysiology of complex regional pain syndrome. Lancet
Neurology, 10(7), 637-648.

Page 12 | Complex Regional Pain Syndrome